2-Methoxyestradiol disulfamate

A synthetic estrogen derivative

2-Methoxyestradiol disulfamate (STX-140) is a synthetic estrogen derivative that has been studied for its potential use in the treatment of various cancers. It is a sulfamate derivative of 2-methoxyestradiol, a naturally occurring estrogen metabolite.

Chemical structure and properties

2-Methoxyestradiol disulfamate is a sulfamate ester of 2-methoxyestradiol. The addition of the sulfamate groups is intended to improve the bioavailability and metabolic stability of the compound compared to its parent compound, 2-methoxyestradiol.

Mechanism of action

2-Methoxyestradiol disulfamate acts by disrupting the microtubule network within cells, which is crucial for cell division. This disruption leads to the inhibition of mitosis and induces apoptosis in rapidly dividing cancer cells. Additionally, it has anti-angiogenic properties, meaning it can inhibit the formation of new blood vessels that tumors need for growth and metastasis.

Potential therapeutic uses

The primary area of research for 2-methoxyestradiol disulfamate is in the treatment of various types of cancer, including breast cancer, prostate cancer, and ovarian cancer. Its ability to target both the cancer cells and the tumor vasculature makes it a promising candidate for cancer therapy.

Pharmacokinetics

The sulfamate modification in 2-methoxyestradiol disulfamate enhances its oral bioavailability compared to 2-methoxyestradiol. This modification allows for more effective systemic delivery and prolonged action in the body.

Research and development

Research on 2-methoxyestradiol disulfamate is ongoing, with studies focusing on its efficacy, safety, and potential as a therapeutic agent in oncology. Clinical trials are being conducted to better understand its role and effectiveness in cancer treatment.

Related pages

• 2-Methoxyestradiol
• Estrogen
• Cancer treatment
• Microtubule

Gallery

• 
  Chemical structure of 2-Methoxyestradiol disulfamate